{
  "type": "hyp",
  "text": "Treatment of a T-lymphocytic cell line with micromolar concentrations of HOCl promoted the appearance of transcription factor NF-kappaB (the heterodimer p50/p65) in the nucleus of the cells even in the absence of de novo protein synthesis. Of six flavonoids tested myricetin was found to strongly inhibit IKK kinase activity and prevent the degradation of IkappaBalpha in the cytosol.\n",
  "self": {
    "NER": {
      "answers": [
        "six",
        "myricetin",
        "IkappaBalpha"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many flavonoids were tested?",
          "What is the name of the flavonoids that inhibit IKK kinase activity",
          "What is the main kinase of the NF-kappaB?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Treatment",
        "a T-lymphocytic cell line",
        "micromolar concentrations",
        "HOCl",
        "the appearance",
        "transcription factor NF-kappaB",
        "(the heterodimer p50/p65",
        "the nucleus",
        "the cells",
        "the absence",
        "de novo protein synthesis",
        "six flavonoids tested myricetin",
        "IKK kinase activity",
        "the degradation",
        "IkappaBalpha",
        "the cytosol"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What promoted the appearance of NF-kappaB in the nucleus of the",
          "What did treatment with micromolar concentrations of HOCl promote the appearance of transcription factor",
          "What was the concentration of HOCl in a T-lymphocytic cell",
          "What substance was used to treat a T-lymphocytic cell line?",
          "What did treatment with micromolar concentrations of HOCl promote?",
          "What is the heterodimer p50/p65?",
          "What is NF-kappaB?",
          "Where did the appearance of NF-kappaB occur?",
          "Where does the NF-kappaB appear in the nucleus of cells?",
          "In what condition did myricetin inhibit IKK kinase activity?",
          "What did myricetin prevent in the absence of?",
          "How many flavonoids were found to inhibit IKK kinase activity?",
          "What did myricetin inhibit?",
          "What does myricetin prevent?",
          "What is the main kinase of the NF-kappaB?",
          "Where did myricetin prevent the degradation of IkappaBalpha?"
        ]
      }
    }
  },
  "asked": {
    "What is the figure that shows that PKC inhibition with Ro-31-8220 did not": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.004320681095123291,
        "ground_truth": {
          "5A": {
            "bertscore": 0.6994669437408447,
            "f1": 0
          }
        }
      }
    },
    "What did Figure 5A show did not alter IkappaBalpha degradation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.011094212532043457,
        "ground_truth": {
          "Ro-31-8220": {
            "bertscore": 0.6039996147155762,
            "f1": 0
          }
        }
      }
    },
    "What did Ro-31-8220 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005357861518859863,
        "ground_truth": {
          "M-CSF": {
            "bertscore": 0.6617133021354675,
            "f1": 0
          },
          "NF-kappaB p65": {
            "bertscore": 0.6318015456199646,
            "f1": 0
          }
        }
      }
    },
    "What degradation did Ro-31-8220 not alter?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0008094906806945801,
        "ground_truth": {
          "IkappaBalpha": {
            "bertscore": 0.6275320649147034,
            "f1": 0
          }
        }
      }
    },
    "What did Ro-31-8220 not alter?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005472302436828613,
        "ground_truth": {
          "Figure 5A PKC inhibition": {
            "bertscore": 0.6492019295692444,
            "f1": 0
          },
          "M-CSF-induced IkappaBalpha degradation": {
            "bertscore": 0.5741342306137085,
            "f1": 0
          },
          "M-CSF-induced PKC activity": {
            "bertscore": 0.5999372601509094,
            "f1": 0
          }
        }
      }
    },
    "What did the Ro-31-8220 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0008235573768615723,
        "ground_truth": {
          "NF-kappaB transcriptional activity": {
            "bertscore": 0.6126886606216431,
            "f1": 0
          }
        }
      }
    },
    "What did the PKC inhibition with Ro-31-8220 do?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0004419684410095215,
        "ground_truth": {
          "an alternative pathway": {
            "bertscore": 0.6820722222328186,
            "f1": 0
          }
        }
      }
    },
    "What pathway did M-CSF-induced PKC inhibition inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.002247154712677002,
        "ground_truth": {
          "post-translational modification": {
            "bertscore": 0.7120372653007507,
            "f1": 0
          }
        }
      }
    }
  }
}